Ligand Receives FDA Orphan Designation for Captisol-Enabled Topiramate Injection
July 26, 2013 at 06:37 AM EDT
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND ) announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for its proprietary Captisol-enabled™ Topiramate Injection for the treatment
